学术代表(J12128)

上海汇伦医药科技有限公司

Shanghai research and technology company of the Huilun pharmaceutical group, whose parent Shanghai Huilun Life Science and Technology was founded in 2004 as an innovative biopharmaceutical company developing, manufacturing and marketing high quality small molecule medicines. Runs drug discovery and development across oncology, cardiovascular, digestive and gynaecological treatment, with programmes including relugolix, levoleucovorin and sivelestat sodium, and works alongside the group's Jiangsu manufacturing operation.